Topic Forum 8











Attenzione: apre in una nuova finestra.

8 Monday, September 3, 4:30 - 6:15 pm
Molecular Biology
Chairs: G. Nardone (Naples) – S. Krishnadath (Amsterdam)
Discussant: R.F. Souza (Dallas)
Secretart: A. Pacha (Amsterdam)

  • Is malignant degeneration of Barrett's esophagus a clonal disease? A. Pacha (Amsterdam)
  • Is there a model for  Barrett’s esophagus to predict progression to esophageal adenocarcinoma? K. Parikh (Amsterdam)
  • Is there a reliable prognostic or diagnostic biomarker test to predict progression of Barrett’s esophagus? A. Pacha (Amsterdam)
  • What genes are involved in the development of esophageal squamous epithelium during embryogenesis and at birth? N.S. Buttar (Rochester, MN)
  • What is the role of CDX-2 in the development of the gut and esophagus Barrett’s esophagus? D. Tosh (Bath)
  • Which morphogenes play a role in Barrett’s esophagus? S. Krishnadath (Amsterdam)
  • Can the in-vitro model of Barrett’s epithelium to EAC be utilized for chemoprevention studies? K. Das (New Brunswick)
  • Which in vivo models do we have for testing chemopreventive drugs for Barrett’s esophagus? N.S. Buttar (Rochester, MN)
  • Is the surgical animal model for Barrett’s esophagus validated at the molecular level? M.K. Gibson (Pittsburgh)
  • What are the potential  chemopreventive targets in Barrett’s esophagus? N.S. Buttar (Rochester, MN)
  • Which existing drugs  can be used for chemoprevention of Barrett’s esophagus? L.X. Chen (Durham)
  • What junctial proteins predispose patients with reflux to Barrett’s esophagus and esophageal adenocarcinoma? R.C. Orlando (Chapel Hill)